We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
-16.56%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$205B
AUM Growth
-$58.3B
Cap. Flow
-$4.48B
Cap. Flow %
-2.18%
Top 10 Hldgs %
21.11%
Holding
3,330
New
90
Increased
1,600
Reduced
1,393
Closed
130

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.04B
2
UNH icon
UnitedHealth
UNH
+$428M
3
MSFT icon
Microsoft
MSFT
+$410M
4
BAC icon
Bank of America
BAC
+$374M
5
BA icon
Boeing
BA
+$332M

Sector Composition

Rank Sector Weight
1 Technology 22.25%
2 Healthcare 14.77%
3 Financials 12.79%
4 Consumer Discretionary 10.52%
5 Communication Services 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRN icon
1901
Trinity Industries
TRN
$2.38B
$3.52M ﹤0.01%
219,012
+2,714
+1% +$54.3K
CDR
1902
DELISTED
Cedar Realty Trust, Inc
CDR
$3.49M ﹤0.01%
105,793
-46,384
-30% -$716K
GTES icon
1903
Gates Industrial Corporation Ltd.
GTES
$7.15B
$3.48M ﹤0.01%
471,789
+303,791
+181% +$3.37M
PGNX
1904
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$3.48M ﹤0.01%
915,934
+266,409
+41% +$1.15M
CAR icon
1905
Avis
CAR
$5.02B
$3.48M ﹤0.01%
250,122
+28,430
+13% +$851K
LMAT icon
1906
LeMaitre Vascular
LMAT
$1.86B
$3.46M ﹤0.01%
138,971
+24,679
+22% +$762K
MLAB icon
1907
Mesa Laboratories
MLAB
$574M
$3.46M ﹤0.01%
15,295
+7,299
+91% +$1.8M
ATRA icon
1908
Atara Biotherapeutics
ATRA
$76.1M
$3.45M ﹤0.01%
16,222
+4,519
+39% +$1.43M
BTAI icon
1909
BioXcel Therapeutics
BTAI
$27.8M
$3.44M ﹤0.01%
9,634
+8,966
+1,342% +$3.22M
ENIC icon
1910
Enel Chile
ENIC
$6.28B
$3.44M ﹤0.01%
1,035,761
-396,676
-28% -$1.75M
CC icon
1911
Chemours
CC
$2.37B
$3.44M ﹤0.01%
387,434
-232,001
-37% -$3.35M
ALEC icon
1912
Alector
ALEC
$199M
$3.44M ﹤0.01%
142,339
+26,876
+23% +$685K
WLK icon
1913
Westlake Corp
WLK
$9.9B
$3.42M ﹤0.01%
89,548
-330,619
-79% -$18.6M
ALX
1914
Alexander's
ALX
$1.41B
$3.4M ﹤0.01%
10,510
+3,804
+57% +$1.19M
SSYS icon
1915
Stratasys
SSYS
$774M
$3.4M ﹤0.01%
212,867
+10,527
+5% +$192K
FC icon
1916
Franklin Covey
FC
$246M
$3.39M ﹤0.01%
217,883
+111,412
+105% +$3.19M
CNCE
1917
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$3.39M ﹤0.01%
383,035
+54,077
+16% +$533K
R icon
1918
Ryder
R
$10.1B
$3.38M ﹤0.01%
127,938
+14,351
+13% +$604K
LPG icon
1919
Dorian LPG
LPG
$1.96B
$3.38M ﹤0.01%
388,064
-791,477
-67% -$9.35M
CBT icon
1920
Cabot Corp
CBT
$4.52B
$3.38M ﹤0.01%
129,353
-78,668
-38% -$2.99M
FLR icon
1921
Fluor
FLR
$7.96B
$3.38M ﹤0.01%
488,726
+15,129
+3% +$211K
QSR icon
1922
Restaurant Brands International
QSR
$25.8B
$3.37M ﹤0.01%
84,188
-334,764
-80% -$18.9M
SCU
1923
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$3.36M ﹤0.01%
248,103
-244,472
-50% -$5.25M
NAT icon
1924
Nordic American Tanker
NAT
$1.37B
$3.36M ﹤0.01%
740,840
+193,877
+35% +$699K
MATW icon
1925
Matthews International
MATW
$739M
$3.35M ﹤0.01%
138,545
+9,740
+8% +$310K

Similar funds

Nuveen's Q1 2020 Portfolio in Review

As of Q1 2020, Nuveen held 3,330 positions worth $205B, down 22% from $264B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nuveen's Q1 2020 filing shows 90 new, 1,600 increased, 1,393 reduced and 130 closed positions. Its largest new stake was Reynolds Consumer Products: 1,948,067 shares worth $56.8M. The largest sale was Apple, an estimated $1.04B.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q1 2020 buy was Reynolds Consumer Products: 1,948,067 shares worth $56.8M.
  • Nuveen added most to Intel in Q1 2020, an estimated $723M increase.
  • Nuveen's biggest Q1 2020 reduction was Apple, cutting an estimated $1.04B.
  • Nuveen fully exited Liberty Property Trust in Q1 2020, selling an estimated $64M.
  • Nuveen's ten largest holdings make up 21% of its $205B portfolio in Q1 2020.
  • Nuveen opened 90 new positions and closed 130 in Q1 2020.
  • Nuveen's portfolio value fell 22% quarter-over-quarter to $205B.

Based on Nuveen's 13F filing for Q1 2020, filed 14 May 2020.